• Infectious Disease
  • Infectious Diseases

    We provide expert diagnosis and management of infectious disease in children, including both inpatient and outpatient evaluation and care. In the dynamic world of infectious disease, children are the most vulnerable targets. Infectious diseases cause more than half of the deaths of children worldwide and are the most common reason children visit physicians and are admitted to hospitals.

    At Texas Children’s, our team offers compassionate care in a setting created especially for children, from newborns to young adults. Our team of expert physicians uses the latest diagnostic and therapeutic techniques to evaluate and treat patients for common to rare infections including:

    • Bacterial, fungal and congenital infections
    • Bartonella henselae (cat scratch fever)
    • Cytomegalovirus (CMV) and other congenital infections
    • Group B streptococcus
    • Herpes simplex
    • Infectious endocarditis
    • Influenza
    • Pertussis
    • Streptococcus pneumoniae
    • Staphylococcus aureus
    • Tuberculosis (Learn more about how Texas Children's Center for Global Health is helping treat tuberculosis internationally.)

    Additional Conditions Treated

    Texas Children's Infectious Diseases Center's physicians evaluate and treat patients for a range of infectious diseases and infections, including:

    • Fevers of unknown origin
    • Heart-related Kawasaki disease, endocarditis
    • Lymphadenitis
    • Postoperative and hospital-acquired infections
    • Serious infections, including bone and joint; pneumonia (bacterial, TB, viral); central nervous system (meningitis, encephalitis); skin and soft tissue (necrotizing fasciitis); septic shock
    • Travel-related illness such as typhoid fever, malaria
    • Illnesses common to immuno-compromised children, including catheter-related bacteremia
    • Infections related to transplants and malignancies
    • Infections related to technology, such as mechanical ventilation, prosthetic materials
    • Shunt infections, hydrocephalus
    • Problems in newborns including fungal infections, meningitis, severe viral infections, enterovirus and congenital infections

    Infectious Diseases works closely with:


    Research offers the best hope for new solutions to infectious diseases. The top-tier program at Texas Children’s Infectious Diseases Center has attracted significant funding from several national sources, including the Centers for Disease Control and Prevention and the National Institutes of Health. Major groundbreaking studies include:

    • Affect of infection on bone marrow function
    • Antibiotic resistance in pediatric pathogens
    • Cardiac depression in gram-positive sepsis; innate immunity in inflammation
    • Community-acquired MRSA
    • Cytomegalovirus (CMV) infections
    • Effect of infectious diseases on the heart
    • Epidemiology and prevention of Group B streptococcal infections
    • Host defense mechanisms
    • Immunizations, public health policy
    • Infant respiratory diseases and prevention through immunization
    • Pathogenesis of Group A streptococcus pharyngitis
    • Tuberculosis treatment and control

    Research Contributions

    Texas Children's Infectious Diseases Center is home to a number of noted authorities across the spectrum of infectious diseases, including cytomegalovirus (CMV), influenza, bacterial pneumonia, staphylococcus infections and tuberculosis. Our team of expert physicians has published a substantial body of work, including more than 700 peer-reviewed original research papers and one of the most widely used textbooks: the Textbook of Pediatric Infectious Diseases. Additionally, several members hold or have held leadership positions in national pediatric and infectious disease associations. 

    Through collaboration and a steadfast devotion to research and study, the physician-scientists at the Infectious Diseases Center have made critical contributions to their fields. Their work has furthered:

    • A greater understanding of pathogenesis and neurological sequelae of bacterial meningitis
    • The establishment of pharmacokinetics, efficacy and safety of multiple antibiotics
    • The knowledge that the administration of ampicillin to women in labor penetrates amniotic fluid
    • The protective antibody level for GBS and the immunogenicity and safety of a conjugate vaccine for pregnant women
    • The establishment of directly observed therapy as the standard for TB treatment
    • The development of prognostic measures for neurologic sequelae including hearing loss as a result of congenital or perinatal CMV infection
Share email
  • Contact Us

    832-824-4330 - Please ask to speak to the outpatient attending physician.


    West Campus
    Floor 4


    Mon: 8 am - 5 pm
    Tue: 8 am - 5 pm
    Wed: 8 am - 5 pm
    Thu: 8 am - 5 pm
    Fri: 8 am - 5 pm

  • Make a Difference

    Our purpose is simple: to heal sick children. Your support makes a difference in the life of a child.

    Give today